Table 3.

Prevalence of NSAID use [%, (n)] among people with various chronic conditions and medication use

Chronic conditions		NSAID use % (n = 357)		NSAID use (n = 176)		Cox-2 inhibitor use (n = 187)
Joint pain	No	2.2 (23)	< 0.01	1.6 (17)	< 0.01	0.7 (7)	< 0.01
	Yes
	Diagnosed as arthritis	27.6 (247)		11.2 (100)		16.9 (151)
	Not diagnosed as arthritis	6.7 (79)		4.9 (57)		2.0 (23)
Cardiovascular disease/stroke	No	10.2 (289)	< 0.01	5.3 (150)	0.05	5.1 (144)	< 0.01
	Yes	20.0 (60)		8.0 (24)		12.0 (36)
MI/angina	No	10.6 (308)	< 0.01	5.4 (158)	0.28	5.3 (155)	< 0.01
	Yes	18.8 (42)		7.1 (16)		11.6 (26)
> 15% 10 year CVD risk	No	10.4 (214)	0.01	5.6 (115)	0.44	5.0 (103)	< 0.01
	Yes	14.7 (56)		6.6 (25)		8.4 (32)
Hypertension*	No	7.7 (140)	< 0.01	4.6 (83)	< 0.01	3.2 (59)	< 0.01
	Yes	16.0 (217)		6.9 (93)		9.5 (128)
Kidney disease**	No	9.9 (245)	< 0.01	5.4 (134)	0.58	4.7 (116)	< 0.01
	Yes	15.9 (109)		6.0 (41)		10.1 (69)
Primary care provider visits in previous year	None	3.5 (8)	< 0.01	3.1 (7)	< 0.01	0.4 (1)	< 0.01
	1-4	6.5 (103)		3.6 (56)		3.0 (47)
	≥ 5	18.0 (239)		8.4 (111)		10.0 (133)
Medication use
Anti-hypertensives	No	9.3 (211)	< 0.01	5.1 (117)	0.11	4.3 (98)	< 0.01
	Yes	16.3 (146)		6.6 (59)		9.9 (89)
Diuretics	No	10.7 (325)	< 0.01	5.5 (166)	0.31	5.4 (164)	< 0.01
	Yes	24.1 (32)		7.5 (10)		17.3 (23)
ACE inhibitors	No	11.2 (314)	0.69	5.3 (150)	0.15	6.0 (169)	0.43
	Yes	11.9 (43)		7.2 (26)		5.0 (18)
Gastro-esophageal reflux	No	9.0 (243)	< 0.01	4.9 (134)	< 0.01	4.1 (112)	< 0.01
	Yes	24.7 (114)		9.1 (42)		16.3 (75)

*Hypertension: systolic ≥ 140 mm Hg and/or diastolic ≥ 90 mm Hg or use of anti-hypertensive medication.

**Kidney disease: GFR < 60 ml/min/1.73 m², GFR > 60 and proteinuria.